Helix BioPharma (TSE:HBP) Shares Pass Above Fifty Day Moving Average – Here’s Why

Helix BioPharma Corp. (TSE:HBP)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.92 and traded as high as C$1.00. Helix BioPharma shares last traded at C$1.00, with a volume of 25,100 shares.

Helix BioPharma Stock Up 14.9 %

The firm’s 50-day moving average price is C$0.92 and its 200 day moving average price is C$0.71. The company has a current ratio of 0.74, a quick ratio of 1.04 and a debt-to-equity ratio of 773.67. The company has a market capitalization of C$49.02 million, a price-to-earnings ratio of -5.00 and a beta of -0.84.

About Helix BioPharma

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging.